Cargando…

Off-label indications of aspirin in gynaecology and obstetrics outpatients at two Chinese tertiary care hospitals: a retrospective cross-sectional study

OBJECTIVE: To investigate the prevalence of off-label aspirin indications and the level of scientific support for off-label indications of aspirin in gynaecology and obstetrics outpatients. DESIGN: A retrospective cross-sectional study. SETTING: Two tertiary hospitals (a general hospital and a women...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Sijie, Yang, Jianhui, Chen, Yao, Xie, Jingxian, Huang, Yanni, Lin, Wubin, Liao, Yufang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860038/
https://www.ncbi.nlm.nih.gov/pubmed/35190417
http://dx.doi.org/10.1136/bmjopen-2021-050702
_version_ 1784654582757982208
author Shen, Sijie
Yang, Jianhui
Chen, Yao
Xie, Jingxian
Huang, Yanni
Lin, Wubin
Liao, Yufang
author_facet Shen, Sijie
Yang, Jianhui
Chen, Yao
Xie, Jingxian
Huang, Yanni
Lin, Wubin
Liao, Yufang
author_sort Shen, Sijie
collection PubMed
description OBJECTIVE: To investigate the prevalence of off-label aspirin indications and the level of scientific support for off-label indications of aspirin in gynaecology and obstetrics outpatients. DESIGN: A retrospective cross-sectional study. SETTING: Two tertiary hospitals (a general hospital and a women and children’s specialised hospital) in Xiamen, a city located on the southeastern coast of China. PARTICIPANTS: A total of 4257 prescriptions were included for 2091 female patients aged >18 who visited the gynaecology and obstetrics outpatient clinics and received aspirin treatment. OUTCOME MEASURES: The primary measure of this study was the proportion of off-label indications and of off-label indications supported by strong scientific evidence. Evidence from clinical guidelines and Micromedex is shown using descriptive statements. On-label indications of drugs in the same class as aspirin were also referred to for off-label aspirin use without strong evidence support. RESULTS: All indications of aspirin on outpatient prescriptions were determined as off-label use in this study. The most frequent off-label indication was recurrent miscarriage (2244 prescriptions, 52.71%). Totally, 30.94% of the prescriptions were supported by strong evidence for indications, including recurrent miscarriage with antiphospholipid syndrome and prophylaxis for pre-eclampsia. No drugs in the same class as aspirin had on-label indications for off-label aspirin use without strong evidence support. CONCLUSIONS: This study demonstrated that all indications of aspirin used in gynaecology and obstetrics outpatients at the two tertiary hospitals were off-label and not always supported by strong evidence, implicating that physicians should be cautious when issuing off-label prescriptions. More original clinical research on off-label aspirin use is needed to provide reference for routine clinical practice.
format Online
Article
Text
id pubmed-8860038
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-88600382022-03-08 Off-label indications of aspirin in gynaecology and obstetrics outpatients at two Chinese tertiary care hospitals: a retrospective cross-sectional study Shen, Sijie Yang, Jianhui Chen, Yao Xie, Jingxian Huang, Yanni Lin, Wubin Liao, Yufang BMJ Open Evidence Based Practice OBJECTIVE: To investigate the prevalence of off-label aspirin indications and the level of scientific support for off-label indications of aspirin in gynaecology and obstetrics outpatients. DESIGN: A retrospective cross-sectional study. SETTING: Two tertiary hospitals (a general hospital and a women and children’s specialised hospital) in Xiamen, a city located on the southeastern coast of China. PARTICIPANTS: A total of 4257 prescriptions were included for 2091 female patients aged >18 who visited the gynaecology and obstetrics outpatient clinics and received aspirin treatment. OUTCOME MEASURES: The primary measure of this study was the proportion of off-label indications and of off-label indications supported by strong scientific evidence. Evidence from clinical guidelines and Micromedex is shown using descriptive statements. On-label indications of drugs in the same class as aspirin were also referred to for off-label aspirin use without strong evidence support. RESULTS: All indications of aspirin on outpatient prescriptions were determined as off-label use in this study. The most frequent off-label indication was recurrent miscarriage (2244 prescriptions, 52.71%). Totally, 30.94% of the prescriptions were supported by strong evidence for indications, including recurrent miscarriage with antiphospholipid syndrome and prophylaxis for pre-eclampsia. No drugs in the same class as aspirin had on-label indications for off-label aspirin use without strong evidence support. CONCLUSIONS: This study demonstrated that all indications of aspirin used in gynaecology and obstetrics outpatients at the two tertiary hospitals were off-label and not always supported by strong evidence, implicating that physicians should be cautious when issuing off-label prescriptions. More original clinical research on off-label aspirin use is needed to provide reference for routine clinical practice. BMJ Publishing Group 2022-02-18 /pmc/articles/PMC8860038/ /pubmed/35190417 http://dx.doi.org/10.1136/bmjopen-2021-050702 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Evidence Based Practice
Shen, Sijie
Yang, Jianhui
Chen, Yao
Xie, Jingxian
Huang, Yanni
Lin, Wubin
Liao, Yufang
Off-label indications of aspirin in gynaecology and obstetrics outpatients at two Chinese tertiary care hospitals: a retrospective cross-sectional study
title Off-label indications of aspirin in gynaecology and obstetrics outpatients at two Chinese tertiary care hospitals: a retrospective cross-sectional study
title_full Off-label indications of aspirin in gynaecology and obstetrics outpatients at two Chinese tertiary care hospitals: a retrospective cross-sectional study
title_fullStr Off-label indications of aspirin in gynaecology and obstetrics outpatients at two Chinese tertiary care hospitals: a retrospective cross-sectional study
title_full_unstemmed Off-label indications of aspirin in gynaecology and obstetrics outpatients at two Chinese tertiary care hospitals: a retrospective cross-sectional study
title_short Off-label indications of aspirin in gynaecology and obstetrics outpatients at two Chinese tertiary care hospitals: a retrospective cross-sectional study
title_sort off-label indications of aspirin in gynaecology and obstetrics outpatients at two chinese tertiary care hospitals: a retrospective cross-sectional study
topic Evidence Based Practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860038/
https://www.ncbi.nlm.nih.gov/pubmed/35190417
http://dx.doi.org/10.1136/bmjopen-2021-050702
work_keys_str_mv AT shensijie offlabelindicationsofaspiriningynaecologyandobstetricsoutpatientsattwochinesetertiarycarehospitalsaretrospectivecrosssectionalstudy
AT yangjianhui offlabelindicationsofaspiriningynaecologyandobstetricsoutpatientsattwochinesetertiarycarehospitalsaretrospectivecrosssectionalstudy
AT chenyao offlabelindicationsofaspiriningynaecologyandobstetricsoutpatientsattwochinesetertiarycarehospitalsaretrospectivecrosssectionalstudy
AT xiejingxian offlabelindicationsofaspiriningynaecologyandobstetricsoutpatientsattwochinesetertiarycarehospitalsaretrospectivecrosssectionalstudy
AT huangyanni offlabelindicationsofaspiriningynaecologyandobstetricsoutpatientsattwochinesetertiarycarehospitalsaretrospectivecrosssectionalstudy
AT linwubin offlabelindicationsofaspiriningynaecologyandobstetricsoutpatientsattwochinesetertiarycarehospitalsaretrospectivecrosssectionalstudy
AT liaoyufang offlabelindicationsofaspiriningynaecologyandobstetricsoutpatientsattwochinesetertiarycarehospitalsaretrospectivecrosssectionalstudy